Nav: Home

Rapamycin tones down the toxicity of HIV-1 reactivation strategies

January 17, 2017

Although patients infected with HIV-1 can successfully manage the disease by taking antiretroviral therapies, these therapies cannot completely eradicate the virus because HIV-1 can persist in a latent reservoir of T cells without replicating. More complete eradication of HIV-1 infection could be achieved using therapies that reactivate the virus in the latent reservoir, but the existing strategies are considered too toxic to use as treatments in HIV-1 patients. This week in the JCI, work performed in Robert Siliciano's lab at Johns Hopkins University School of Medicine evaluated whether a strategy combining T cell activation with the immunosuppressive drug rapamycin could reactivate latent HIV-1 reservoirs without causing toxic side effects. Rapamycin treatment reduced proinflammatory cytokine release and other signs of toxicity without decreasing HIV-1 reactivation in T cells from HIV-1-infected individuals. Importantly, the rapamycin treatment did not impair the ability of the immune system to recognize infected T cells. These findings indicate that rapamycin could be used to reduce the toxicity of strategies targeting the HIV-1 latent reservoir.
-end-
TITLE: Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity

AUTHOR CONTACT:

Robert F. Siliciano
Johns Hopkins University School Of Medicine
rsiliciano@jhmi.edu

View this article at:http://www.jci.org/articles/view/89552?key=5d32d232ee55831ed7e7

JCI Journals

Related Virus Articles:

New insights into how the Zika virus causes microcephaly
Scientists have uncovered why Zika virus may specifically target neural stem cells in the developing brain, potentially leading to microcephaly.
New Zika virus inhibitor identified
Compound could serve as basis for drugs to prevent neurological complications of Zika.
Zeroing in on the Zika virus
Hobman has been announced as one of three Canadian scientists who have received funding from the Canadian Institutes of Health Research (CIHR) for their teams to study the Zika virus.
What does it take for an AIDS virus to infect a person?
Researchers examined the characteristics of HIV-1 strains that were successful in traversing the genital mucosa that forms a boundary to entry by viruses and bacteria.
Cough virus kills liver cancer cells and hepatitis virus
A virus that causes childhood coughs and colds could help in the fight against primary liver cancer, according to a study.
Characterizing the Zika virus genome
The sudden emergence of the Zika virus epidemic in Latin America in 2015-16 has caught the scientific world unawares.
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions.
What does Zika virus mean for the children of the Americas?
A special communication article published online by JAMA Pediatrics explores whether new paradigms in child health may emerge because of Zika virus.
Predicting the spread of the Zika virus
A new tool by Japan-based researchers predicts the risk of Zika virus importation and local transmission for 189 countries.
An old new weapon against emerging Chikungunya virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.

Related Virus Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...